Sunday, November 8, 2026

USD/CNH Bearish By 2% In The Last 21 Sessions

ViaNews Editorial Team

November 29, 2023

USD/CNH Bearish By 2% In The Last 21 Sessions

(VIANEWS) - USD/CNH (USDCNH) has been up by 2.57% for the last 21 sessions. At 14:06 EST on Wednesday, 29 November, USD/CNH (USDCNH) is $7.13.

USD/CNH's yearly highs and lows, it's 0.29% up from its 52-week low and 0.01% down from its 52-week high.

News about

  • Eur/usd remains capped below 1.0950, eyes on eurozone inflation, US GDP data. According to FXStreet on Monday, 27 November, "The downside risks to growth in Germany, Europe's largest economy might exert some selling pressure on the Euro (EUR) and act as a headwind for the EUR/USD pair. "
  • According to FXStreet on Monday, 27 November, "Further north, EUR/USD might face resistance around the August top of 1.1064 (August 10) and another weekly peak of 1.1149 (July 27), all preceding the 2023 high of 1.1275 (July 18)."
  • Eur/usd price analysis: continues the winning streak on weaker US dollar, trades near 1.0950. According to FXStreet on Monday, 27 November, "If the pair manages to break through that level, it could empower EUR/USD bulls to tackle the resistance zone near the psychological level of 1.1000.", "The technical signals for the EUR/USD pair are in favor of the ongoing upward movement. "
  • Eur/usd refreshes multi-month peak as fed rate cut bets continue to undermine the USD. According to FXStreet on Tuesday, 28 November, "This will be followed by the flash Eurozone CPI report on Thursday and the US Core PCE Price Index - the Fed's preferred inflation gauge - on Thursday, which, in turn, will drive the EUR/USD pair in the near term.", "Adding to this, the increasing likelihood of earlier rate cuts by the Fed in 2024 compared to the European Central Bank (ECB) turns out to be another factor acting as a tailwind for the EUR/USD pair."

More news about USD/CNH (USDCNH).

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Q4 2026 Biotech Catalyst Season: Regulatory Deadlines and Data Readouts Against Cost Discipline and Slipping Timelines
From late October 2026 to January 2027, mid-cap biotechs cluster pivotal data presentations (ESMO, AHA, AASLD), FDA decision dates (ivonescimab BLA on 2026-11-14, lorundrostat on 2026-12-22) and Q3 earnings. Alongside these, several companies are managing capital: lowering R&D and SG&A guidance, pushing clinical milestones into 2027, authorizing a $400M buyback, and pursuing a delisting. Late-stage programs in oncology, hepatitis delta, hypertension and women's health look near commercial inflection, while cost cuts and delays point to uneven balance-sheet strength.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,996
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,996 facts checked against source5,552 source documents archived
Query this data → isubstrate.com